Determination of essential biomarkers in lung cancer

• Autor(a) principal: Provencio, Mariano
• Data de Publicação: 2022
• Outros Autores: Cobo, Manuel, Rodriguez-Abreu, Delvys, Calvo, Virginia, Carcereny, Enric, Cantero, Alexandra, Bernabé, Reyes, Benitez, Gretel, Castro, Rafael López, Massutí, Bartomeu, del Barco, Edel, García Campelo, Rosario, Guirado, Maria, Camps, Carlos, Ortega, Ana Laura, González Larriba, Jose Luis, Sánchez, Alfredo, Casal, Joaquín, Sala, M. Angeles, Juan-Vidal, Oscar, Bosch-Barrera, Joaquim, Oramas, Juana, Dómine, Manuel, Trigo, Jose Manuel, Blanco, Remei, Calzas, Julia, Morilla, Idoia, Padilla, Airam, Pimentão, João, Sousa, Pedro A., Torrente, Maria
• Tipo de documento: Artigo
• Idioma: eng
• Título da fonte: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
• Texto Completo: http://hdl.handle.net/10362/146094
• topic: Biomarkers; Metastatic lung cancer; Targeted therapies; Testing; Oncology; Genetics; Cancer Research; SDG 3 - Good Health and Well-being

Funding Information: This study was supported by the European Union Horizon 2020 Research and Innovation Program under grant agreement n° 875160 CLARIFY project. Funding Information: The authors thank all investigators who participated in the RRTT registry: Dr. Pilar Diaz (Complejo Asistencial Universitario de León, Spain), Dr. Rosa M. Villatoro (Hospital Costa del Sol, Marbella, Spain), Dr. Pilar Lianes (Hospital de Mataró, Barcelona, Spain), Dr. M. Rosario Hernández (Hospital Ntra. Sra Sonsoles, Ávila, Spain), Dr. Juana Oramas (Hospital Universitario de Canarias, Santa Cruz de Tenerife, Spain), Dr. Karmele Areses (Complejo Hospitalario e Ourense, Spain), Dr. Rafael Lopez (Hospital Clinico Universitario de Valladolid, Spain), Dr. Julio Ocaña (Hospital CIMA Sanitas, Barcelona, Spain), Dra. María Gonzalez Cao (Hospital Universario Quiron-Dexeus, Barcelona, Spain), Dr. Noemí Reguart (Hospital Clinic Barcelona, Spain), Dr. Manuel Fernández (Hospital HM la Esperanza, Santiago de Compostela, A Coruña, Spain), Dr. Luis Enrique Chara (Hospital Universitario de Guadalajara, Spain), Dr. Judit Rubio (Hospital Universitario de Móstoles, Madrid, Spain), Dr. Alfonso Gurpide (Clinica Universitaria de Navarra, Pamplona, Spain), Dr. Ana Reyes García (Hospital Universitario Río Hortega, Valladolid, Spain), Dr. Beatriz Esteban (Hospital General de Segovia, Spain). We also thank the patients, their families, all the participating clinical teams and the Spanish Lung Cancer Group for coordinating the study. M.P. contributed to the conception and design of the study. D.R.A., M.T., A.LO., C.C., V.C., M.D., G.B., A.P., A.C., R.B., R.G.C., E.C., B.M., J.B.B., O.J.V., M.C., E.d.B., R.L.C., J.L.G., A.S., M.G., R.L.C., J.C., J.O., M.A.S., J.M.T., R.B., J.C., and I.M. contributed to acquisition of study data. M.P. and M.T. contributed to data analysis and writing of the manuscript, J. P. and P.A.S. to the writing and revision. All authors had full access to all the data in the study and final responsibility for the decision to submit for publication. The author(s) read and approved the final manuscript. Publisher Copyright: © 2022, The Author(s).